Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Everest Organics Ltd

Your Vote -

Buy

66.67%

Hold

0.00%

Sell

33.33%

66.67%

6 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Everest Organics Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Everest Organics - General Updates-Newspaper Publication

    30 Aug 2025, 10:59AM Everest Organics Limited has informed the Exchange about the copy of newspaper publications.
  • Everest Organics posts Q1 net profit of Rs 1.41 cr

    5 Aug 2025, 4:20PM The company reported standalone net profit during the quarter stood at Rs 1.41 crore compared to net loss of Rs 6.09 crore in the previous year quarte
  • Everest Organics - Appointment of Company Secretary and Compliance Officer

    5 Aug 2025, 4:09PM Everest Organics Limited informed the exchange about the appointment of Company Secretary and Compliance Officer.
  • Everest Organics - Announcement under Regulation 30 (LODR)-Change in Management

    5 Aug 2025, 4:06PM Everest Organics Limited has informed the exchange about the Change in Management.
  • Everest Organics - Financial Results For Quarter Ended June 30, 2025.

    5 Aug 2025, 3:56PM Everest Organics Limited submitted Unaudited Financial Results for quarter ended June 30, 2025
  • Everest Organics - Board Meeting Outcome for Outcome Of Board Meeting Held On August 05, 2025 For Quarter Ended June 30, 2025

    5 Aug 2025, 3:46PM Everest Organics Limited exchange about the Outcome of Board Meeting held on August 05, 2025 .
  • Everest Organics - Board Meeting Intimation for 1. Unaudited Financial Results Along With Limited Review Report For Quarte

    28 Jul 2025, 3:21PM Everest Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2025 ,inter alia, to consider and
  • Everest Organics has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2025

    19 Jul 2025, 7:01AM As of June 2025, 60.78% is owned by Promoters and 39.22% by Public. <p align=justify> Among Promoters holding, Indian Promoters holds 59.04% and Forei
  • Everest Organics - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    15 Jul 2025, 11:36AM Certificate under regulation 74(5) of SEBI(DP) Regulations, 2018 for the quarter ended June 30, 2025.
  • Everest Organics - Issue Of Duplicate Share Certificate

    14 Jul 2025, 1:15PM Everest Organics Limited has informed exchange about the issue of duplicate share certificates.

Key fundamentals

Evaluate the intrinsic value of Everest Organics Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 117.8214 103.6287 97.2623 85.5772 66.4962
Liabilities 117.8214 103.6287 97.2623 85.5772 66.4962
Equity 9.7105 8 8 8 8
Gross Profit 7.2229 10.9866 0.9298 6.4276 22.8428
Net Profit -1.2903 0.1392 -0.1822 1.1437 13.7149
Cash From Operating Activities -5.3769 16.4201 18.4179 13.7374 13.533
NPM(%) -0.8 0.07 -0.09 0.57 7.55
Revenue 159.479 197.2412 183.0484 200.0466 181.5668
Expenses 152.2561 186.2546 182.1186 193.619 158.724
ROE(%) -3.05 0.32 -0.43 2.71 32.49

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Everest Organics Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 802.00 0.50 72.66 225.21 301.39 0.62
Lotus Eye Hospital and Institute Ltd 116.91 6.94 376.90 820.62 3.55 0.00
Bharat Immunological and Biologicals Corporation Ltd 21.30 -1.07 0.00 1703.88 -39.50 0.00
Astec Lifesciences Ltd 879.30 2.33 0.00 773.87 -604.77 0.00

Company Info

Everest Organics Limited, a company with its registered office at Hyderabad, was incorporated on 19th February, 1993. The company has subsequently obtained the certificate of commencement of business on 17th March, 1993. The factory of the company is situated at Aroor Village, Sadasivpet Mandal, Medak district, A.P. The unit is eligible for incentives like State Subsidy, Sales Tax deferment and Power Tariff etc., as the unit is being located in Notified Backward Area. The main objects of the company is to carry on the business of manufacturing, selling of bulk drugs and formulations, which are fully set out in its Memorandum and Articles of Association and are also mentioned below in this prospectus. M/s Everest Organics Limited, envisages to set up a project with a total outlay of Rs.1850 lakhs for Manufacturing Bulk Drugs namely; Para Hydroxy Phenyl Clycine (PHPC) (totally an Import substitute), Omeprazole, Ciprofloxacin, at Aroor Village, Sadasivpet Mandal, Medak district, A.P. As per the schedule given in the project appraisal, the plant will go into Commercial Production by the end of September, 1995. However, the management is confident of implementing the project ahead of the timeframe given in the implementation schedule and starting Commercial Production by July, 1995, i.e.; 2 months ahead of schedule. 2020 - Everest Organics successfully develops Remdesivir API

Everest Organics Limited, a company with its registered office at Hyderabad, was incorporated on 19th February, 1993. The company has subsequently obtained the certificate of commencement of business on 17th March, 1993. The factory of the company is situated at Aroor Village, Sadasivpet Mandal, Medak district, A.P. The unit is eligible for incentives like State Subsidy, Sales Tax deferment and Power Tariff etc., as the unit is being located in Notified Backward Area. The main objects of the company is to carry on the business of manufacturing, selling of bulk drugs and formulations, which are fully set out in its Memorandum and Articles of Association and are also mentioned below in this prospectus. M/s Everest Organics Limited, envisages to set up a project with a total outlay of Rs.1850 lakhs for Manufacturing Bulk Drugs namely; Para Hydroxy Phenyl Clycine (PHPC) (totally an Import substitute), Omeprazole, Ciprofloxacin, at Aroor Village, Sadasivpet Mandal, Medak district, A.P. As per the schedule given in the project appraisal, the plant will go into Commercial Production by the end of September, 1995. However, the management is confident of implementing the project ahead of the timeframe given in the implementation schedule and starting Commercial Production by July, 1995, i.e.; 2 months ahead of schedule. 2020 - Everest Organics successfully develops Remdesivir API

Read More

Parent Organisation

Everest Organics Ltd.

Founded

19/02/1993

Managing Director

Dr.Srikakarlapudi Sirisha

NSE Symbol

FAQ

The current price of Everest Organics Ltd is

The 52-week high for Everest Organics Ltd is

The market capitalization of Everest Organics Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Everest Organics Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Everest Organics Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Everest Organics Ltd shares.

The CEO of Everest Organics Ltd is Dr.Srikakarlapudi Sirisha, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT